The question
Does tau spreading between connected nerve cells drive degeneration?
This is the specific idea being tested.
The Hypothesis Critic · A guide for everyone
Tau Propagation Hypothesis
Does tau spreading between connected nerve cells drive degeneration?
What you need to knowTau can spread, but nerve-cell vulnerability better explains some patterns of damage.Relative explanatory fit: Alternative ranked ahead
Why the alternative fits better: Cell type, tau interactions and internal protein handling help explain which cells die. Tau movement is a separate question.
Review summary
Claim assessed: Pathological tau spreads between anatomically connected neurons by templated seeding, and this cell-to-cell propagation drives the progression of neurodegeneration in tauopathies.
Finding: The preregistered weakest-link conjunction returns Γ. Longitudinal human network progression, recipient-host conversion experiments and causal modifiers make the claim more than association alone. None of the assembled lines selectively establishes that spontaneous templated neuronal propagation is necessary for the neuronal-loss trajectory across tauopathies. Defined laboratory capability is credited, while selective propagation mediation is the remaining gate.
Key points
- SC1: Tau pathology shows reproducible spatial progression along connected brain systems. — HSEF Γ, Moderate confidence.
- SC2: Pathogenic tau physically transfers between anatomically connected neurons under endogenous conditions. — HSEF Γ, Moderate confidence.
- SC3: Transferred tau templates pathological conversion of recipient endogenous tau. — HSEF Γ, Moderate confidence.
- SC4: Cell-to-cell templated propagation causally drives neurodegeneration progression. — HSEF Γ, Moderate confidence.
Verdict and review details
- Evidence grade
- HSEF Γ — Mechanistically plausible, partial system support
- Confidence
- Moderate
- Framework
- HSEF v5.3
- Review date
- Literature cutoff
- Published
- Review attribution (recorded)
- Codex
Evidence scope: 66 primary reports; literature cutoff 2026-10-06; source examination UTC date 2026-10-06; bounded critical review, not exhaustive systematic review.
The grade applies to the stated claim. Model rankings and individual subclaim grades remain separate from the overall causal-evidence grade.
Full scientific assessment and references · Scorecard (JSON) · Review source (Markdown)
The result at a glance
Tau can spread, but nerve-cell vulnerability better explains some patterns of damage.
Read the labels in this illustration
THE MAIN FINDING Tau can spread, but nerve-cell vulnerability better explains some patterns of damage. The idea Does tau spreading between connected nerve cells drive degeneration? Tau spreads between connected nerve cells Degeneration progresses Proposed chain — plausible, not established What fits better Best fit in this review Nerve cells differ in vulnerability Tau nearby, cell intact Resilient cell type Tau inside, cell degenerating Vulnerable cell type Protein handling differs Internal protein machinery Same tau exposure can lead to different cell fates What remains uncertain Which cell types are most vulnerable, and why How much damage comes from tau movement itself Whether blocking transfer alone protects nerve cells Evidence comes from cells, animals, and people — each setting carries different weight. Cell type, tau interactions and internal protein handling help explain which cells die. Tau movement is a separate question. Conceptual illustration
Best fit in this review
Nerve cells differ in vulnerability
Cell type, tau interactions and internal protein handling help explain which cells die. Tau movement is a separate question.
Evidence for the stated claim
Plausible, not established
A higher rank means a better fit to the evidence in this comparison. It does not prove every part of the leading explanation.
Which explanation fits?
Another explanation fits better.
A separate question from the causal evidence grade
How does this explanation compare with alternatives?
Alternative ranked aheadThe reviewed hypothesis ranks 2 among 5 models compared; 1 alternative model(s) hold first rank for this stated claim.
Claim under review: rank 2 among 5 compared models.
Leading explanation: Cell-autonomous selective vulnerability.
Position in this comparison: Next after leading rank.
The causal grade asks how well the stated causal claim is established. This comparison asks which of the assessed explanations fits the reviewed findings better. A leading explanation can remain unproven. Models can overlap or include the tested mechanism; an alternative ahead does not make that mechanism irrelevant. These ordinal ranks apply within this review; they do not measure the size of a difference or rank scientific strength across topics.
Read the labels in this illustration
TWO EXPLANATIONS, COMPARED A · The idea under review Does tau spreading between connected nerve cells drive degeneration? Proposed chain Tau spreads between connected nerve cells Degeneration progresses Each arrow is a proposal, not a proven step. Cell type, tau interactions and internal protein handling help explain which cells die. Tau movement is a separate question. B · Leading explanation Another explanation fits better Nerve cells differ in vulnerability Tau movement between cells Transfer happens — but does it drive the damage? Cell type and protein handling better explain which cells die A better fit is not proof of every part of the explanation. These explanations can overlap. Conceptual illustration
Idea being tested · rank 2
Does tau spreading between connected nerve cells drive degeneration?
Plausible, not established for the stated claim.
Best fit in this review · rank 1
Nerve cells differ in vulnerability
Cell type, tau interactions and internal protein handling help explain which cells die. Tau movement is a separate question.
These explanations can overlap. Ranking their fit to the evidence is separate from deciding how firmly a cause has been established.
See all the explanations compared
Rank 1: Cell-autonomous selective vulnerability — Intrinsic neuronal type, synaptic tau binding and proteostasis help determine which cells degenerate.
Rank 2: Templated neuronal propagation — Donor tau transfer recruits recipient substrate and helps advance pathology.
Rank 3: Transfer without neurotoxicity — Transferred material can move independently of recipient templating or lethal consequences.
Rank 4: Upstream proteostatic failure — Endolysosomal escape and cellular clearance determine tau competence and intrinsic toxicity.
Rank 5: Shared microenvironment pseudo-spread — Network activity and glial environments create correlated pathology without obligatory neuron-to-neuron transfer.
What this means
?
Plausible, not established
Tau can spread, but nerve-cell vulnerability better explains some patterns of damage.
Evidence rating: Γ · Moderate confidence. How the evidence was assessed.
The important distinction
Cell type, tau interactions and internal protein handling help explain which cells die. Tau movement is a separate question.
Health and treatment
This is an assessment of a causal explanation, not proof that a particular supplement, diet, test, or treatment improves health. A treatment claim needs studies that test the intervention in people and measure meaningful benefits and harms. These findings can help frame research and informed clinical questions, but they do not identify what is right for one person.
From an idea to an explanation
Seeing two things together does not prove one causes the other.
What is observed?
Look for the proposed factor and the outcome, in the people or systems covered by the claim.
What else explains it?
Nerve cells differ in vulnerability. Cell type, tau interactions and internal protein handling help explain which cells die. Tau movement is a separate question.
What test tells them apart?
Block transfer without changing tau's source or cell survival, measuring conversion and degeneration separately.
Key questions
The key parts of the idea
These illustrations show the key questions tested in the review. They are conceptual drawings, not microscope images or experimental results.
What to test next
What evidence would make the answer clearer?
Read the labels in this illustration
WHAT WOULD MAKE THE ANSWER CLEARER A research question Block transfer without changing tau's source or cell survival, measuring conversion and degeneration separately. then then Change the proposed cause Proposed test Tau transfer is blocked Transfer blocked Source tau and cell survival kept the same Transfer allowed — control Both arms are followed over time. Measure the relevant outcome Proposed test Tau conversion in recipient cells Degeneration, measured separately Tau source — kept unchanged Measured in both arms. Check the result independently Proposed test First team measures Second team repeats An independent check of the result. Same measures, fresh eyes — no shared data until the end. This storyboard shows the logic of a test. It does not show a result. The question is which changes come first — and which ones follow. Conceptual illustration
A useful next question
Block transfer without changing tau's source or cell survival, measuring conversion and degeneration separately.
Change the proposed cause
Check that the intended change really happened.
Measure the relevant outcome
Allow for other factors and compare with suitable controls.
Check whether it holds up
Look for independent confirmation and the limits of the effect.
These are questions for research, not a claim that the proposed studies have already succeeded.
Read the scientific study designs
Proposed tests: 1 test design(s) are registered in the scorecard.
In plain terms, researchers would change the proposed cause, check that it changed as intended, then measure a meaningful outcome while controlling plausible alternatives. The result should be able to support or count against the claim—not only show that a pathway exists.
Experiment 1: Registered boundary experiment
Study design: In spontaneous tauopathy with physiological donor and recipient tau, induce a selective transfer/conversion block after pathology onset and provide mechanistically matched rescue, with source tau burden and neuronal physiology held comparable.
What would be measured: Direct recipient lineage conversion, regional spread, blinded neuron counts and cognitive/functional trajectory
Important controls: Donor and recipient allele tags, source load, synaptic/lysosomal viability, transfer-independent intracellular toxicity and sham rescue
Result that would support the claim: Selective interruption reduces new recipient conversion and subsequent neuronal loss, and matched rescue restores both
Result that would count against it: Verified selective interruption leaves neuronal-loss progression unchanged or worsens it while matched intrinsic-toxicity control explains the trajectory
Explore the evidence
Read the complete scientific review.
Follow the studies, detailed comparisons and evidence ratings behind this guide.
Open the scientific review →